Spectacular Merck Annual Report 2014
Annual Report we take a closer look at four global trends.
Merck annual report 2014. If you would like a hard copy of the Annual Report on Form 10-K or Proxy Statement please complete the information request form on the Information Request page. Cause results to differ materially from those described in the forward-looking statements can be found in Mercks 2013 Annual Report on Form 10-K and the. Taking the share split into account this resulted in earnings per share of 266 2013.
In May 2014 Merck and Endocyte Inc. Merck 2009 Annual Report Pages. Merck 2013 Annual Report Pages.
The company anticipates full-year 2021 revenue range to be between 518 billion and 538 billion including a. Endocyte the Companys collaboration partner announced the withdrawal of the conditional MAA from the EMA for vintafolide for the treatment of adult patients with folate receptor-positive platinum-resistant ovarian cancer in combination with pegylated liposomal doxorubicin PLD. Welcome to our 2014 Annual Report.
Our magazine shows how Merck is meeting them positioning itself optimally for the future and taking decisive steps to help shape tomorrow. KARL-LUDWIG KLEY Chairman of the Executive Board. Click the button below to request a report when hardcopies become available.
Merck 2011 Annual Report Pages. Merck 2010 Annual Report Pages. Merck announced first-quarter sales of 121 billion in-line with first-quarter 2020.
GSK Annual Report 2014 3 This year in further efforts to improve our corporate reporting we have incorporated more information about our responsible business approach and performance within the Annual Report as we move towards aligning with the principles of Integrated Reporting. While life expectancy is increasing birth rates are declining even in many dynamic emerging countries. We are all pursuing one goal.